Cillia

Cillia is a combined oral contraceptive containing ethinylestradiol and levonorgestrel. It is used for birth control and may help regulate menstrual cycles. This medication is manufactured by Litcon Pharma Se in the EU.

Cillia is primarily used as a birth control pill to prevent pregnancy. It works by preventing ovulation and altering the cervical mucus to hinder sperm movement. Some individuals may also use it to manage menstrual irregularities or reduce symptoms of premenstrual syndrome (PMS).

Common effects of Cillia may include changes in menstrual bleeding patterns, such as lighter or more regular periods. Some users might experience mild side effects like nausea, breast tenderness, or headaches. These effects vary among individuals and typically subside as the body adjusts to the medication.

Cillia should be used under medical supervision. It is important to inform your healthcare provider about any pre-existing conditions, especially those related to blood clots, liver disease, or hormonal imbalances. Regular follow-ups are recommended to monitor for any adverse effects.

Cillia may interact with certain medications, including those that induce liver enzymes, such as some anticonvulsants and antibiotics. Alcohol consumption should be moderated, as it can affect the efficacy of the medication. Always consult a healthcare provider before starting any new medication while using Cillia.